Clinical Trials in Colorado

Showing 11121-11140 of 18,143 trials

Novel Endoluminal Clinical TreAtment of Reflux

NCT03090607

This is a prospective, multi-center, double-blind, crossover, randomized controlled trial designed to demonstrate the safety and efficacy of Aluvra for the treatment of GERD.

GERD

Impleo Medical Inc.100 participantsStarted Nov 2017

Los Angeles, California, United States • Palo Alto, California, United States • Englewood, Colorado, United States +7 more locations

COMPLETEDPhase 446 miles

Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis

NCT01732770

This study will compare the effectiveness of denosumab treatment every 6 months with once yearly zoledronic acid treatment on bone mineral density (BMD) at various skeletal sites.

Post Menopausal Osteoporosis

Amgen643 participantsStarted Nov 2012

Santa Monica, California, United States • Lakewood, Colorado, United States • Longmont, Colorado, United States +42 more locations

Novel Endoluminal Clinical TreAtment of Reflux

Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis

Find Trials by Condition in Colorado

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Genetic Analysis of Hereditary Prostate Cancer

Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

VITROS Immunodiagnostic Products NT-proBNP II

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Peanut Oral Immunotherapy in Children

Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency

A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event